Drug Trial Radar · NCT04855045
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
Last checked: Nov 19, 2026Latest source record: Mar 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
15
Planned (sponsor's estimate)
Start
Mar 23, 2021
Primary completion
Dec 2023
Study completion Dec 2023
Sponsor
- Lead sponsor
- ProQR TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 years, up to 7 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PQ-110-005 (BRIGHTEN) is an open-label, dose escalation and double-masked, randomized, controlled study evaluating safety and tolerability of sepofarsen administered via intravitreal (IVT) injection in pediatric subjects (\<8 years of age) with LCA10 due to the c.2991+1655A\>G mutation over 24 months of treatment.
Conditions
- Leber Congenital Amaurosis 10
- Blindness
- Leber Congenital Amaurosis
- Vision Disorders
- Sensation Disorders
- Neurologic Manifestations
- Eye Diseases
- Eye Disorders Congenital
- Retinal Disease
- Retinal Degeneration
- Retinal Dystrophies
Interventions
sepofarsenDrug
RNA antisense oligonucleotide for intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of ocular adverse events (AEs)Time frame: 24 months
- Incidence and severity of non-ocular adverse events (AEs)Time frame: 24 months
Locations
9 sites in 7 countries. Site status is shown where the registry gives one.
Universitair Ziekenhuis Gent (UZ)
Ghent, Belgium · Recruiting
INRET Clinica e Centro de Pesquisa / Santa Casa BH
Belo Horizonte, Brazil · Recruiting
Federal University of Sao Paulo - Hospital Sao Paulo
São Paulo, Brazil · Recruiting
University of Alberta
Edmonton, Alberta, Canada · Not yet recruiting
Justus-Liebig Universität - Department of Ophthalmology
Giessen, Germany · Recruiting
University of Tübingen - Institute for Ophthalmic Research
Tübingen, Germany · Not yet recruiting
Eye Clinic University of Campania Liugi Vanvitelli
Naples, Italy · Not yet recruiting
Amsterdam University Medica Center - Locatie AMC
Amsterdam, Netherlands · Recruiting
Moorfields Eye Hospital - NHS Foundation Trust
London, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.